Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-04

Clinical Trial Update: Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression [Phase 2, Phase 3]

View source ↗

Summary

This entry reports an update on a Phase 2/3 trial comparing ziprasidone to the sertraline/haloperidol combination for psychotic depression, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Sertraline (Sertraline)
  • Ziprasidone (ziprasidone)

Snippet

Sponsor: Duke University | Conditions: Affective Disorders | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-06-04